A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...

HIV prevention used to be wrapped in red tape, judgment, and long doctor visits. But Mistr is flipping the whole system on ...

“Your work saved my life,” Denison, now an advocate for HIV-positive women ... a three-part trial intended to evaluate various forms of PrEP (oral, injectable, and vaginal ring) in women ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new ...

Nina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...

It is the first time that a PrEP trial has been shown to prevent any HIV infections from slipping through the net, according to Gilead, and showed a subcutaneous injection with lenacapavir every ...

In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...

The current administration has pulled millions in HIV-related grants and cut staffing positions essential to research and prevention — a reversal from Trump’s promise six years ago to end the HIV ...

UConn Health in Farmington has been working to reach underserved populations and educate them about PrEP for HIV. PrEP, or ...

HIV and other STIs every three to six months. Even patients who decide to take their PrEP pills on an episodic rather than ...